[HTML][HTML] Historical review of the causes of cancer

CB Blackadar - World journal of clinical oncology, 2016 - ncbi.nlm.nih.gov
In the early 1900s, numerous seminal publications reported that high rates of cancer
occurred in certain occupations. During this period, work with infectious agents produced …

Effectiveness and safety of extending intrauterine device duration: a systematic review

AJ Ti, AH Roe, KC Whitehouse, RA Smith… - American journal of …, 2020 - Elsevier
Objective To systematically review the literature to determine if extended use of intrauterine
devices, including the copper or levonorgestrel intrauterine device, beyond approved …

Nanomedicinal strategies as efficient therapeutic interventions for delivery of cancer vaccines

S Beg, SM Kawish, SK Panda, M Tarique… - Seminars in cancer …, 2021 - Elsevier
The applications of gene therapy-based treatment of cancers were started almost two
decades back as a boon over the chemotherapeutic treatment strategies. Gene therapy …

[HTML][HTML] Antitumor action of the peroxisome proliferator‑activated receptor‑γ agonist rosiglitazone in hepatocellular carcinoma

QF Bo, XM Sun, J Liu, XM Sui… - Oncology Letters, 2015 - spandidos-publications.com
The inhibition of apoptosis in cancer cells is the major pathological feature of hepatic
carcinoma. Rosiglitazone (RGZ), a ligand for peroxisome proliferator‑activated receptor γ …

Hepatocellular carcinoma after kidney transplantation: analysis of Hong Kong renal registry

CY Cheung, MF Lam, KM Chow, W Lee, YL Cheng… - Renal …, 2014 - Taylor & Francis
Kidney transplant recipients have increased risk of cancers when compared with the general
population. Hepatocellular carcinoma (HCC) is extremely important in Asia where hepatitis …

Human Microbiome and Malignancy: Principles, Mechanisms, and Challenges

M Ruwali, R Shukla - Pathogenicity and Drug Resistance of Human …, 2019 - Springer
Cancer is a disease caused by several factors, and there are interindividual differences in
susceptibility toward cancer. Recent advances in cancer studies have failed to explain the …